Playback speed
10 seconds
ESMO 2023 Insights: "CheckMate 238 Trial - Adjuvant Nivo vs. Ipi in Resected Stage III/IV Melanoma"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Paolo A. Ascierto
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Paolo A. Ascierto
86 views
November 24, 2023
Login to view comments.
Click here to Login